home chevron_right R&D chevron_right Science

Science

"UPPTHERA develops innovative drugs employing TPD science"

UPS(Ubiquitin Proteasome System) is an intracellular protein degradation pathway which breaks about 80% of intracellular proteins : TPD(Targeted Protein Degradation) is a novel drug modality degrading disease-causing proteins by harnessing the UPS.
① PROTAC draws POI intro a ternary complex with E3 Ligase
② E3 Ligase then polyubiquitinates lysine residues on the surface of POI
③ Proteasome recognizes the poly-ubiqutin chain and degrades POI

Degraders have competitive edges in solving unmet needs which have not been solved by traditional drug modalities

Small Molecule Inhibitor

SM inhibitor could be developed only for a protein that possesses binding pocket wity an active site

(15% of total disease-causing protein)

'Inhibition' of disease-causing proteins
Low target selectivity / Off-target issue
1 drug inhibits 1 protein

(Occupancy-driven MoA)

VS

Degrader (PROTAC)

PROTAC could degrade a disease-causing protein as long as it binds the protein in any manners to make it ubquitinated, regardless of presence of binding pocket in the protein
'Degradation' of disease-causing proteins
Enhance target selectivity
1 drug degrades multiple proteins

(Event-driven MoA)